Chicago, Illinois
Phase 1 colorectal cancer trials in Chicago, IL
16 Phase 1 colorectal cancer studies are recruiting participants at sites in Chicago as of November 17, 2026, according to ClinicalTrials.gov. Colorectal Phase 1 Trials can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Chicago at a glance
- 16 studies are recruiting at a site in Chicago.
- By phase: Phase 1 (7), Phase 1/2 (9).
- By sponsor: industry (12), university, hospital or other (4).
- Most recent update to one of these records: November 17, 2026.
Studies recruiting in Chicago
Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
A Phase 1/2 Study of IAM1363 in HER2 Cancers
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Iambic Therapeutics, Inc
- Study site
- University of Chicago
- Registry record
- NCT06253871 · updated
A Study to Investigate CEA-PRIT 2.0 in Participants With Metastatic Colorectal Cancer (mCRC)
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Hoffmann-La Roche
- Study site
- The University of Chicago Medical Center
- Registry record
- NCT07416552 · updated
SMP-3124LP in Adults With Advanced Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Sumitomo Pharma America, Inc.
- Study sites
- Northwestern Medicine Cancer Center · The University of Chicago
- Registry record
- NCT06526819 · updated
AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Avacta Life Sciences Ltd
- Study site
- The University of Chicago
- Registry record
- NCT07454642 · updated
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Exelixis
- Study site
- Exelixis Clinical Site #26
- Registry record
- NCT05176483 · updated
PRE-ISPY Phase I/II Oncology Platform Program
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- QuantumLeap Healthcare Collaborative
- Study site
- The University of Chicago Medicine Comprehensive Cancer Center
- Registry record
- NCT05868226 · updated
Manipulation of the Gut Microbiome by a Standardized Preoperative Diet to Prevent Colorectal Cancer Recurrence and Metastasis Following Surgery
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- University of Chicago
- Study site
- University of Chicago
- Registry record
- NCT06349590 · updated
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- Phase 1/2
- From 12 months, up to 30 years
- All sexes
- Sponsor
- Children's Oncology Group
- Study site
- Lurie Children's Hospital-Chicago
- Registry record
- NCT04851119 · updated
BMS-986504 in Combination With Pemetrexed for the Treatment of Metastatic Solid Tumors With MTAP Deletion
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Northwestern University
- Study site
- Northwestern University
- Registry record
- NCT07594626 · updated
Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Xencor, Inc.
- Study site
- Xencor Investigative Site
- Registry record
- NCT05433142 · updated
A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Alentis Therapeutics AG
- Study site
- The University of Chicago Medical Center - Oncology
- Registry record
- NCT07169734 · updated
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- AbbVie
- Study sites
- University of Chicago Medical Center /ID# 276271 · University of Illinois Hospital and Health Sciences System /ID# 251750
- Registry record
- NCT05005403 · updated
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
- Phase 1/2
- Ages 12 and older
- All sexes
- Sponsor
- Turning Point Therapeutics, Inc.
- Study site
- University of Chicago
- Registry record
- NCT03093116 · updated
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- 858 Therapeutics, Inc.
- Study site
- University of Chicago Medical Center
- Registry record
- NCT06395519 · updated
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Clasp Therapeutics, Inc.
- Study site
- The University of Chicago Comprehensive Cancer Center
- Registry record
- NCT06778863 · updated
A Study of NX-1607 in Adults With Advanced Malignancies
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Nurix Therapeutics, Inc.
- Study site
- University of Chicago
- Registry record
- NCT05107674 · updated
Source: ClinicalTrials.gov. Data processed . See every colorectal cancer study recruiting in Chicago, IL on ClinicalTrials.gov.
Ask about studies near Chicago
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 17, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that are in Phase 1, including early Phase 1 and combined Phase 1/2, as each study is coded in the registry.
Colorectal Phase 1 Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections